Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,051 | -16,020 | -54,323 | -41,050 | -28,349 |
| Depreciation Amortization | 255 | 117 | 369 | 259 | 167 |
| Accounts receivable | -645 | 1 | 2 | 8 | -23 |
| Accounts payable and accrued liabilities | -3,829 | -3,811 | 4,261 | 1,368 | -75 |
| Other Working Capital | -6,494 | -6,685 | -10,464 | -9,179 | -7,194 |
| Other Operating Activity | 9,633 | 7,441 | 5,486 | 6,081 | 5,674 |
| Operating Cash Flow | $-29,131 | $-18,957 | $-54,669 | $-42,513 | $-29,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -376 | -150 | -737 | -461 | -385 |
| Investing Cash Flow | $-376 | $-150 | $-737 | $-461 | $-385 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 240 | N/A | 47,358 | 47,369 | 47,368 |
| Common Stock Repurchased | -1,275 | -731 | -2,059 | -1,042 | -1,042 |
| Financing Cash Flow | $-1,035 | $-731 | $45,299 | $46,327 | $46,326 |
| Beginning Cash Position | 71,335 | 71,335 | 81,441 | 81,441 | 81,441 |
| End Cash Position | 40,793 | 51,497 | 71,334 | 84,794 | 97,582 |
| Net Cash Flow | $-30,542 | $-19,838 | $-10,107 | $3,353 | $16,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,131 | -18,957 | -54,669 | -42,513 | -29,800 |
| Capital Expenditure | -376 | -150 | -737 | -461 | -385 |
| Free Cash Flow | -29,507 | -19,107 | -55,406 | -42,974 | -30,185 |